Anterogen.Co.Ltd (065660) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.37x

Anterogen.Co.Ltd (065660) has a Cash Flow Reinvestment Rate of 0.37x as of September 2025, reinvesting ₩105.11 Million (capex ₩27.45 Million plus investments ₩77.66 Million) from operating cash flow of ₩281.98 Million. Explore reinvestment intensity of Anterogen.Co.Ltd to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.37x

(Capex + Investments) / Operating CF

Total Reinvested

₩105.11 Million

Capex + Investments

Operating Cash Flow

₩281.98 Million

KRW

Capital Expenditures

₩27.45 Million

KRW

Anterogen.Co.Ltd Cash Flow Reinvestment Rate (2015–2017)

Historical reinvestment intensity for Anterogen.Co.Ltd across 2 annual periods. Also explore Anterogen.Co.Ltd balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Anterogen.Co.Ltd (2015–2017)

Year-by-year capital reinvestment analysis for Anterogen.Co.Ltd. For live market cap and broader valuation context, see 065660 stock market capitalisation.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2017	38.22x	₩14.49 Billion	₩379.21 Million	₩637.46 Million	▲ +2460.2%
2015	1.49x	₩1.26 Billion	₩844.49 Million	₩659.00 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow